Video summary
5 Midcaps That Could Turn Into Large Caps | Here's Why?
Main summary
Key takeaways
Finance-focused summary (midcaps → potential large caps)
Core thesis / “migration” framework
- The presenter cites research suggesting wealth migrates more from midcaps to large caps than from small caps to large caps.
- The goal is multi-year upside (~4x–5x) by identifying midcap companies that can reach ~₹1 lakh crore market cap (treated as the definition of “large cap” in the video).
- Working screen / market-cap ranges mentioned:
- Large cap target: ~₹1 lakh cr
- Nifty 50 lowest market cap cited: Max Healthcare ~₹97,000 cr
- Midcap starting range targeted: ~₹15,000–₹20,000 cr
- Implied upside path: midcaps at ₹15k–₹20k cr → ₹95k–₹1 lakh cr (~4x–5x)
Methodology / steps described (as presented)
- Select sectors: pharma, IT, retail, NBFC, building materials, auto components
- Define market-cap thresholds for “mid → large”
- For each company, review:
- Business/sector tailwinds
- Fundamentals
- topline growth
- profitability/margin trends
- acquisition impact
- Order book / AUM / backlog metrics (where applicable)
- Balance sheet / risk
- e.g., debt-free status, leverage
- Valuation sanity
- includes cautions like “slightly rich” for one case
- Catalysts
- Technicals
- one stock is explicitly discussed with moving averages, breakout levels, and wait/watch rules
The 5 companies highlighted
1) Coforge (IT) — potential “Nifty50 soon” setup
Why it could scale
- Presented as an IT leader with enterprise AI moving into production.
- Expansion via acquisitions; highlighted:
- Encora deal
- Signity acquisition
Key numbers / metrics mentioned
- Market cap: ~₹80,000 cr
- Valuation: ~4x price-to-sales (P/S)
- Stock move: fell from ~₹1,900 to ~₹1,000 (~45% drop)
- Order book:
- ~$2.23B for next 12 months
- includes ~$691M organic
- Balance sheet / cash flow:
- “Completely debt-free”
- “Free cash flow”
- “Gives a lot of dividends”
- Revenue mix (as stated):
- 25% Banking/BFSI
- ~23% Hospitality/Travel/Insurance
- Growth:
- Topline growth: ~25% compounded (as cited)
Cited deal catalyst
- Encora deal
- Adds ~28 new Fortune 500 logos
- Expands America footprint
- Mentions UK government/UK work
“Large cap path” logic
- The presenter implies Coforge could move into mega-indices if price confirmation occurs. It’s described as already large-ish, but positioned as a scaling candidate.
Technical analysis (explicit)
- “Taking a base” around the 10-day moving average
- All-time high breakout zone: ~₹2,000
- Rule: “Wait and watch till 2,000”
- If it breaks above ₹2,000 (rejected 3 times), it “becomes one of the Nifty50 companies soon.”
2) Pyramal Finance (NBFC) — scaling via retail/mortgages; AI underwriting
Why it could scale
- Positioned as a top-tier NBFC focused on mortgage/specialty lending.
- Catalysts: expansion in gold loan and focus on MSME.
- Uses AI to improve underwriting quality.
Key numbers / metrics mentioned
- Market cap: ~₹46,000 cr
- AUM: “almost ₹1 lakh crores AUM”
- “Massive PAT” (amount not specified)
- Retail AUM:
- Up ~32% YoY to ~₹91,000 cr
- Mortgages:
- ~₹61,000 cr (home loans + loan against property)
- Wholesale/legacy risk discussion:
- Presenter calls wholesale/legacy books the “scary book” due to prior industry stress
- Mentions Pyramal is trying to reduce exposure (amount not specified)
- Leverage comment:
- “As a lending company, can go up to 3x–4x leverage”
- Mentions potential need for QIPs (dilution/financing risk)
Risk management / caution noted
- Main risk area is wholesale/legacy book; improvement depends on execution in trimming/problem legacy exposure.
Ownership / governance catalyst
- Promoter stake increasing; mentions a promoter change context involving the “Vadva group.”
3) Astral (Building materials: PVC pipes & plumbing/drainage/water systems)
Why it could scale
- Beneficiary of India’s construction cycle continuing.
- Moves toward premiumization (e.g., water tanks, fire sprinklers).
- Competitive tailwind: minimum import price on Chinese PVC tubes reduces dumping pressure.
Key numbers / metrics mentioned
- Total revenue cited: ~₹6,500 cr
- Q1 revenue: ~₹1,500 cr
- Market cap: ~₹41,000 cr
- “Large-cap gap”: another ~₹60,000 cr for large cap (as stated)
- Long-term compounding: ~21% CAGR over 10 years
- Breakout/near-term profit path (as stated):
- “Asian paints” competition referenced
- “Bathware segment nearing break-even”
- Mentions 20–25% target (context: distribution expansion; exact KPI not fully specified)
Performance narrative
- Growth was subdued earlier; “growth has started picking up.”
4) Sonar / Sonar BLW (Auto ancillaries + EV drivetrain; robotics actuators angle)
Note: Subtitle text contains “Sonar BLW you” and later “sonar builder.” The intent appears to be Sonata/sonar BLW-style auto-ancillary coverage, but the ticker is not explicitly provided.
Why it could scale
- EV transition story: increasing BEV share.
- Diversifies into robotics via actuators for joint movement.
- Claims it’s moving “away from China” and building precision manufacturing.
- New JV mentioned with Denso (Japan).
Key numbers / metrics mentioned
- Market cap: ~₹51,000 cr
- Valuation marker: “66p” (likely EPS; unit unclear due to subtitle noise)
- Price performance:
- Last year: ~+80%
- Earlier: reportedly fell from ~700 to ~300, then recovered (exact dates unclear)
- Revenue level:
- Current topline: ~₹4,000 cr
- Order book/backlog:
- ~₹23,000 cr order book
- Target/trajectory stated:
- “Quoting that they will become ₹25,000 cr net order book” (wording slightly unclear)
- BEV/geography mix:
- “50% of full-year revenue” from geography mix (destination mix % mentioned but not named)
- Export revenue expected to grow better (numbers not specified)
Margins / valuation caution
- Presenter says “Some of it is priced in” and robotics “not priced in.”
- Short-term caution: “It is a little expensive right now on the upper side.”
5) Loris / Laurus Labs (Pharma) — mentioned but excluded from “midcap” list at time of video
Why it was mentioned
- The presenter previously tracked a pharma candidate as a midcap, but by recording time it had become a large cap.
- Therefore, the presenter wants to avoid including it in the “midcap → large cap” list.
Key numbers / status
- Market cap at time of mention: ~₹97,000 cr
- Earlier tracking market cap: ~₹25,000 cr
- Name appears as “Loris Labs” / “Lotus labs” due to subtitle errors; likely Laurus Labs (ticker not provided).
Cross-cutting risk and valuation notes from the presenter
- IT (Coforge): execution via acquisitions; stock temporarily down despite fundamentals; technical trigger at ₹2,000.
- NBFC (Pyramal Finance): main risk is wholesale/legacy book; possible QIPs and 3x–4x leverage create financing/dilution considerations.
- Building materials (Astral): may be near a large-cap valuation ceiling; competition and input/output volatility noted (Mexico/China dumping narrative referenced).
- Auto/EV (Sonar BLW): “expensive in short term,” but robotics upside may be underpriced.
- Pharma: excluded because it already reached large-cap market cap.
Disclosures / disclaimers
- No explicit “not financial advice” disclaimer appears in the provided subtitles.
- The presenter frames guidance as a video and discusses research/teaching; only clear compliance text is none shown in the subtitles.
Tickers / instruments / markets mentioned
- Nifty 50 index (used for large-cap market cap reference)
- No specific tickers provided.
- Instruments/assets referenced:
- Market capitalization (market-cap thresholds)
- Order book / backlog (IT and auto)
- AUM / PAT (for NBFC)
- QIPs (equity issuance risk tool mentioned)
- Gold loans (NBFC product)
- PVC pipes / water tanks / fire sprinklers (building materials products)
- Geography/sector mentions:
- America, Europe, UK
- Fortune 500
- China (for PVC input/export context)
Presenters / sources
- Presenter: Shashang Gurupa
- Source referenced: Motilal Trillion Dollar Wealth Research (cited as informing the mid-to-large wealth migration claim)